Cargando…

Rationale for the Use of Prostaglandins and Phosphodiesterase Inhibitors in the Treatment of Functional Bladder Disorders

In this paper a general discussion of the available data on the role of prostaglandin (PG) and phosphodiesterase is discussed. Functional studies would be a next step to understand the functional meaning of the data described in this paper. The data presented are a basis for further research on sele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahnama'i, Mohammad Sajjad, Van Koeveringe, Gommert A., Van Kerrebroeck, Philip E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955285/ https://www.ncbi.nlm.nih.gov/pubmed/24693500 http://dx.doi.org/10.5812/numonthly.14088

Ejemplares similares

Overactive Bladder Syndrome and the Potential Role of Prostaglandins and Phosphodiesterases: An Introduction
por: Rahnama'i, Mohammad Sajjad, et al.
Publicado: (2013)

The effect of indomethacin on the muscarinic induced contractions in the isolated normal guinea pig urinary bladder
por: Rahnama’i, Mohammad S, et al.
Publicado: (2013)

The Role of the Periaqueductal Gray Matter in Lower Urinary Tract Function
por: Zare, Aryo, et al.
Publicado: (2018)

Parcellation of human periaqueductal gray at 7‐T fMRI in full and empty bladder state: The foundation to study dynamic connectivity changes related to lower urinary tract functioning
por: de Rijk, Mathijs M., et al.
Publicado: (2021)

Neuromodulation for functional bladder disorders in patients with multiple sclerosis
por: Rahnama’i, Mohammad Sajjad
Publicado: (2019)

The value of urodynamic tools to guide patient selection in sacral neuromodulation
por: Drossaerts, Jamie, et al.
Publicado: (2015)

A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies
por: van Renterghem, Koenraad, et al.
Publicado: (2009)

Between-subject similarity of functional connectivity-based organization of the human periaqueductal gray related to autonomic processing
por: de Rijk, Mathijs M., et al.
Publicado: (2022)

Sacral neuromodulation in patients with refractory overactive bladder symptoms after failed Botulinum toxin therapy: Results in a large cohort of patients
por: Reekmans, Mathias, et al.
Publicado: (2021)

Intravesical Injection of Abobotulinumtoxin-A in Patients with Bladder Pain Syndrome/Interstitial Cystitis
por: Rahnama’i, Mohammad-Sajjad, et al.
Publicado: (2023)

Multidisciplinary treatment for functional urological disorders with psychosomatic comorbidity in a tertiary pelvic care center—A retrospective cohort study
por: van Knippenberg, Vera, et al.
Publicado: (2022)

Changes in voiding behavior in a mouse model of Alzheimer’s disease
por: Biallosterski, B. T., et al.
Publicado: (2015)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
por: Javan Balegh Marand, Aida, et al.
Publicado: (2023)

Age-related changes in murine bladder structure and sensory innervation: a multiphoton microscopy quantitative analysis
por: Schueth, Anna, et al.
Publicado: (2016)

Effect of phosphodiesterase inhibitors in the bladder
por: Chughtai, Bilal, et al.
Publicado: (2015)

Bladder Pain Syndrome and Interstitial Cystitis Beyond Horizon: Reports from the Global Interstitial Cystitis/Bladder Pain Society (GIBS) Meeting 2019 Mumbai – India
por: Rahnama'i, Mohammad Sajjad, et al.
Publicado: (2020)

Assessment of Brainstem Functional Organization in Healthy Adults and Overactive Bladder Patients Using Ultra-High Field fMRI
por: Fernández Chadily, Susana, et al.
Publicado: (2023)

The Maximal Urethral Pressure at Rest and during Normal Bladder Filling Is Only Determined by the Activity of the Urethral Smooth Musculature in the Female
por: Venema, Pieter L., et al.
Publicado: (2023)

The localization of cyclo-oxygenase immuno-reactivity (COX I-IR) to the urothelium and to interstitial cells in the bladder wall
por: de Jongh, R, et al.
Publicado: (2009)

Prostate Cancer Drug Therapy: What Have Clinicians Missed During the COVID-19 Pandemic
por: Rahnama’i, M. S.
Publicado: (2022)

Neuronal Activation in the Periaqueductal Gray Matter Upon Electrical Stimulation of the Bladder
por: Meriaux, Céline, et al.
Publicado: (2018)

The Scientific Value of Abstracts on Prostate Cancer Presented at the European Association of Urology Congresses
por: Ataei, Jasmin, et al.
Publicado: (2021)

Can the predictive value of multiparametric MRI for prostate cancer be improved by a liquid biopsy with SelectMDx?
por: Rahnama'i, Mohammad Sajjad, et al.
Publicado: (2021)

Microbiome in Lower Urinary Tract Symptoms (LUTSs): Mapping the State of the Art with Bibliometric Analysis
por: Mostafaei, Hadi, et al.
Publicado: (2023)

Dystrophin is expressed in smooth muscle and afferent nerve fibers in the rat urinary bladder
por: Lionarons, Judith M., et al.
Publicado: (2019)

Stress-Induced Changes in Trophic Factor Expression in the Rodent Urinary Bladder: Possible Links With Angiogenesis
por: de Rijk, Mathijs M., et al.
Publicado: (2022)

Expression and function of phosphodiesterases (PDEs) in the rat urinary bladder
por: Zhu, Xiaofei, et al.
Publicado: (2017)

Combination phosphodiesterase type 4 inhibitor and phosphodiesterase type 5 inhibitor treatment reduces non-voiding contraction in a rat model of overactive bladder
por: Balog, Brian M., et al.
Publicado: (2019)

Current Management of Post-radical Prostatectomy Urinary Incontinence
por: Rahnama'i, Mohammad S., et al.
Publicado: (2021)

Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19)
por: Solaimanzadeh, Isaac
Publicado: (2020)

Phosphodiesterase Inhibitors for Alzheimer’s Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale
por: Sanders, Owen, et al.
Publicado: (2020)

Erratum to: Expression and function of phosphodiesterases (PDEs) in the rat urinary bladder
por: Zhu, Xiaofei, et al.
Publicado: (2017)

Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction
por: Moschos, Marilita M, et al.
Publicado: (2016)

Replacement Adaptor 09106 for patients with a dynamic graciloplasty or patients with sacral neuromodulation and abdominal implantable pulse generators: a retrospective, single centre, Stage 2a/2b development IDEAL case series
por: Assmann, Roman, et al.
Publicado: (2022)

Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis
por: Mease, Philip J.
Publicado: (2014)

New Prospective Phosphodiesterase Inhibitors: Phosphorylated Oxazole Derivatives in Treatment of Hypertension
por: Nizhenkovska, Iryna V., et al.
Publicado: (2023)

Erratum to: Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis
por: Mease, Philip J.
Publicado: (2015)

Evolution of Phosphodiesterase-5 Inhibitors
por: Moon, Du Geon
Publicado: (2015)

Stimulation Parameters for Sacral Neuromodulation on Lower Urinary Tract and Bowel Dysfunction–Related Clinical Outcome: A Systematic Review
por: Assmann, Roman, et al.
Publicado: (2020)

Sacral Neuromodulation for Lower Urinary Tract and Bowel Dysfunction in Animal Models: A Systematic Review With Focus on Stimulation Parameter Selection
por: Douven, Perla, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n2n7ah935mfj6aveg5n0bdghtr